Option chain shows key data for Sangui Biotech Intl's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sangui Biotech Intl.

Sangui Biotech Intl (OTC:SGBI) Stock, Option Chain

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.

News

Penny Stocks

Interview

General

BALY

SGBI

Deviate To Win is an interview series featuring executives and investors who have won in business by taking chances and doing things a little bit differently. The podcast is hosted by Jason Ader, founder and CEO of SpringOwl Asset Management, and is produced by Benzinga. 

Podcast: How Soo Kim Helped Turn Bally&#39;s Into A Triple Threat

Contracts

NLSN

Why Nielsen&#39;s Stock Is Trading Higher Today

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

AFOM

AFTM

AIVN

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALRM

ALTM

AMMJ

APDN

ARCW

ATIS

AVLIF

AXRX

BCAP

BEGI

BERK

BIOC

BOSC

BSRC

BVTK

CANB

CBLI

CCAN

CDEV

CELC

CGIX

CLXT

CMCT

CNAB

CNXS

CRON

CTMX

CVEO

CYDVF

CYTR

DFFN

DLPH

DRIO

DRNK

DRRSF

EACTF

EEGI

ELVT

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ENBL

ENLC

ETRN

EVARF

EXTN

EZPW

FAMI

FOSL

FRNKF

FRXX

GBHPF

GHSI

GLOG

GLOP

HEXO

HITIF

HRVOF

HSDT

IBAL

ICNAF

IDWM

IDXG

IIVI

INAP

INND

INQD

IONKF

ISIG

JMIA

JRJC

KLXE

LGORF

AMERICAN LITHIUM CORP ORD by American Lithium Corp.

LIACF

LKSD

LTNC

MARA

MINE

Stocks That Hit 52-Week Lows On Monday

SANGUI BIOTECH INTL INC by Sangui BioTech International, Inc.

Sangui Biotech International Inc

Rumors

Analyst Ratings

Watching Sinclair; Hearing Zacks Home Run Investor Picks Stock

Deviate To Win is an interview series featuring executives and investors who have won in business by taking chances and doing things a little bit differently. The podcast is hosted by Jason Ader, founder and CEO of<a href="https://springowl.com/"> SpringOwl Asset Management</a>, and is produced by Benzinga.&nbsp;
On the first episode of Deviate To Win, SpringOwl Asset Management Founder and CEO Jason Ader spoke with Soo Kim, the chairman of Bally&#39;s Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baly#NYSE">BALY</a>) and founding partner of the hedge fund Standard General.&nbsp;
<h3>Background On Bally&rsquo;s And Standard General</h3>
Standard General has initiated massive changes since taking a stake in the casino&mdash;then known as Twin River&mdash;in 2016, and has since become its largest shareholder. In 2019, Kim was named chairman of the board.&nbsp;
That same year, the company completed a reverse merger with Dover Downs Gaming &amp; Entertainment, which took the company public. In 2020, the company went on a shopping spree.&nbsp;
First, they paid $51 million for three Colorado casinos from Affinity Gaming. This was followed by acquisitions in New Jersey, Louisiana, Nevada, Missouri, Mississippi, and Illinois. In October, the company paid $20 million to buy the Bally&rsquo;s trademark from Cesear&rsquo;s Entertainment and rebranded all its properties under the Bally brand.&nbsp;
In November, Bally&rsquo;s paid $125 million for Bet.Works, a U.S. sports betting platform, which the company said will enable it to scale its online sports betting offerings.&nbsp;
Bally also reached a naming rights deal with Sinclair Broadcast Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgbi#NASDAQ">SGBI</a>), and in April the company&rsquo;s regional sports networks were rebranded as &ldquo;Bally Sports.&rdquo;
In the episode, Kim discusses what led to those transactions, and how each of them fit into the long-term vision for Bally&rsquo;s.&nbsp;
&ldquo;We wanted to be the first gaming company that essentially disruptiveness ourselves, essentially willing to put our casinos on the line so that we can embrace an online future because we felt that in the end, the online future was was was bright and ultimately it didn&#39;t harm the physical casinos, but was this amazing compliment that added a lot of growth to it,&rdquo; he said.&nbsp;
Among the other topics discussed:
<ul>
<li>How regional sports networks helps Bally&rsquo;s acquire more customers (8:10)</li>
<li>How Bally&rsquo;s is thinking about esports (21:12)</li>
<li>Kim&rsquo;s business role models (29:10)</li>
</ul>
Listen to the full episode below. Don&rsquo;t forget to rate and review to help others find it!&nbsp;
Jason&rsquo;s book, &ldquo;Deviate To Win: Insights From A Turnaround Investor&rdquo; <a href="https://www.amazon.com/Deviate-Win-Insights-Turnaround-Investor/dp/1506908969" style="text-decoration-line:none">can be purchased on Amazon here</a>.&nbsp;
<iframe allow="encrypted-media" frameborder="0" height="232" src="https://open.spotify.com/embed/episode/6YIdgCsXC6EagOKvtHIo9R" width="100%"></iframe>
DISCLAIMER
This podcast is meant to be used for informational purposes only and not investment advice. Hosts and guests may maintain positions in securities discussed. All opinions on Deviate To Win are the opinions of the host and guest, and do not represent those of SpringOwl Asset Management. Deviate To Win is produced by Benzinga.
<div>&nbsp;</div>

Listen to Episode 1 Of Deviate To Win, The New Podcast From Jason Ader, Featuring The Chairman Of Bally's

Nielsen Holdings (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nlsn#NYSE">NLSN</a>) shares are trading higher on Thursday, after the company announced <a href="https://www.prnewswire.com/news-releases/nielsen-and-sinclair-broadcast-group-announce-multi-year-agreement-301033844.html">a renewal </a>in its multi-year deal with Sinclair Broadcast Group Inc. (Nasdaq: <a class="ticker" href="https://www.benzinga.com/stock/sgbi#Nasdaq">SGBI</a>) for all of Sinclair&#39;s 191 local TV stations, 89 markets&nbsp;and 22 sports brands.
The agreement includes Nielsen Scarborough, Ad Intel, Arianna and Grabix and Digital in TV ratings measurement in select markets and platforms.
Nielsen is an American information, data and measurement firm which&nbsp;operates in over 100 countries and employs approximately 44,000 people worldwide.
Nielsen shares were trading up 6.07% at $12.58 on Thursday. The stock has a 52-week high of $27.28 and a 52-week low of $11.62.

Why Nielsen's Stock Is Trading Higher Today

DTMXF

GODYF

Sinclair Broadcast Group, Inc. (NASDAQ: <a class="ticker" href="/stock/sbgi#NASDAQ">SBGI</a>) revealed that its fully-owned subsidiary, Sinclair Television Group, Inc., has received an extension of the maturity date of some loans apart from commitments under its existing bank credit facility until July 31, 2021.
 
	Sinclair unit indicated it was able to get the extension of the maturity date of 80.3% of its pro rata commitments under its revolving credit facility, as well as term A loans to July 31, 2021 from April 9, 2018. The company indicated that the amount comprised of $485.2 million in revolving credit commitments and $139.5 million of term loan A loans.

	According to the company, the remaining $153.5 million of outstanding term A loans would mature April 9, 2018. The company added that extending lenders have also agreed to a reduction in some pricing terms in connection with the Loans based on satisfying some covenant ratios.

	The stock shed 0.79 percent on Tuesday.

Financing

SBGI

Sinclair Extends And Amend Bank Credit Agreement

Sangui Biotech Intl

Comments

Sangui Biotech Intl

Sangui Biotech Intl (SGBI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga